Covagen

Covagen was a biotech company that developed a novel platform technology for discovery and development of bispecific antibodies. The company was acquired by Janssen in 2014.

Daniel Mahony

Managed by

Daniel O'Mahony

Partner

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top